Unijules Life Sciences Limited - Company Profile

It is a pharma public limited company based in Nagpur, Maharashtra, India, established in 2006.
2006 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Unijules Life Sciences Limited

Unijules Life Sciences Limited, a active public limited company, was established on 16 January 2006 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U52311MH2006PLC158928. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹13.86 Cr.

It upholds a active non-compliant status. Employing 57 professional, Its leadership includes Pawan Kumar Chokhani (Director), Pranav Pawan Chokhani (Director), Ankit Pawan Chokhani (Director). Past directors included Faiz Zakir Vali, Vinayak Gopalkrishna Kudva, Gulam Abbas Hassonjee. It holds ₹817.76 Cr open charges and ₹49.75 Cr settled loans. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at B- 35, Midc Industrial Area Kalmeshwar, Nagpur, Maharashtra, 441501.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52311MH2006PLC158928

  • Registration Number

    158928

  • Incorporation Date

    16 January 2006

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹13.86 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 13.86 Cr
  • Company Age 20 Year, 30 Days
  • Last Filing with ROC 31 Mar 2018
  • Open Charges ₹ 817.76 Cr
  • Satisfied Charges ₹ 49.75 Cr
  • Revenue Growth **** -4.56%
  • Profit Growth **** -149.83%
  • Ebitda **** -33.44%
  • Net Worth -6.36%
  • Total Assets -8.87%
Company report

Unijules Life Sciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unijules Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Unijules Life Sciences Limited?
Current Directors
Name Designation Appointment Date Status
Pawan Kumar Chokhani Director 01 Jan 2026 Current
Pranav Pawan Chokhani Director 01 Jan 2026 Current
Ankit Pawan Chokhani Director 01 Jan 2026 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Apr 2006 Past
Pramod Abcsdd Director 01 Mar 2008 Past
Pramod Abcsdd Director 30 Sep 2013 Past
Pramod Abcsdd Director 01 Apr 2007 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past
Pramod Abcsdd Additional Director 09 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unijules Life Sciences.

Unijules Life Sciences Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 4.56% decrease. The company also saw a substantial fall in profitability, with a 149.83% decrease in profit. The company's net worth dipped by a decrease of 6.36%.

Unijules Life Sciences revenue growth over time
Unijules Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -4.56%
*******
*******
*******
*******
Revenue from Operations
*******
 -5.70%
*******
*******
*******
*******
Total Assets
*******
 -8.87%
*******
*******
*******
*******
Profit or Loss
*******
 -149.83%
*******
*******
*******
*******
Net Worth
*******
 -6.36%
*******
*******
*******
*******
EBITDA
*******
 -33.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unijules Life Sciences?

In 2018, Unijules Life Sciences had a promoter holding of 59.97% and a public holding of 40.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,177,624,400.00

Satisfied Charges

₹497,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 210.53 Cr
  • State Bank Of India : 160.70 Cr
  • Others : 148.14 Cr
  • The Shamrao Vithal Co-Op. Bank Ltd. : 134.80 Cr
  • Punjab National Bank : 48.00 Cr
  • Others : 115.60 Cr
Latest Charge Details
Date Lender Amount Status
15 Apr 2014 Others ₹4.00 Cr Open
26 Mar 2013 Punjab National Bank ₹48.00 Cr Open
17 Sep 2012 Yes Bank Limited ₹10.00 Cr Open
29 Aug 2012 Bank Of Maharashtra ₹43.00 Cr Open
28 Mar 2012 Others ₹4.25 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Unijules Life Sciences?

Unijules Life Sciences has a workforce of 57 employees as of Jan 19, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unijules Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unijules Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unijules Life Sciences
Recent Activity within the Organization
  • Director Appointment

    The activity Pawan Kumar Chokhani was appointed as a Director was appointed as a Director on 01 Jan 2026 & has been associated with this company since 1 month 14 days . was completed.

  • Director Appointment

    Progress on Pranav Pawan Chokhani was appointed as a Director was appointed as a Director on 01 Jan 2026 & has been associated with this company since 1 month 14 days . was documented.

  • Director Appointment

    Ankit Pawan Chokhani was appointed as a Director was appointed as a Director on 01 Jan 2026 & has been associated with this company since 1 month 14 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Unijules Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was documented.

  • Charges

    A charge with Others of Rs. 4.00 Cr registered on 15 Apr 2014 with Charge ID 10497128 was modified on 10 Jul 2018. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 4.25 Cr registered on 28 Mar 2012 with Charge ID 10356491 was modified on 10 Jul 2018. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unijules Life Sciences Limited?

The CIN of Unijules Life Sciences Limited is U52311MH2006PLC158928.

Where is Unijules Life Sciences Limited headquartered?

Unijules Life Sciences Limited is headquartered at B- 35, Midc Industrial Area Kalmeshwar, Nagpur, Maharashtra, 441501.

When was Unijules Life Sciences Limited incorporated?

Unijules Life Sciences Limited was incorporated on 16 January 2006.

Who are the current directors of Unijules Life Sciences Limited?

The current directors of Unijules Life Sciences Limited are

What is the primary industry of Unijules Life Sciences Limited?

The primary industry of Unijules Life Sciences Limited is Manufacturing.

Is Unijules Life Sciences Limited a listed company?

Unijules Life Sciences Limited is unlisted.

What is the capital structure of Unijules Life Sciences Limited?

The authorized capital of Unijules Life Sciences Limited is ₹25.00 Cr, and the paid-up capital is ₹13.86 Cr.

What is the compliance status of Unijules Life Sciences Limited?

The compliance status of Unijules Life Sciences Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available